Evidence mapPaperPMID 40890761Full record

ReviewCell communication and signaling : CCS2025

Targeting phase separation: a promising treatment option for hepatocellular carcinoma.

Ziling Zhou, Sikan Jin, Xiaoming Li, Dan Zhang, Shengxi Zhang, He Zhou, Ji Cai, Tao Song, Xianyao Wang, Qinghong Kong and 3 more

Abstract readReview
In one paragraph

Review in Cell communication and signaling : CCS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ziling ZhouDepartment of Immunology, Zunyi Medical University, Zunyi, 563000, China.
Sikan JinDepartment of Immunology, Zunyi Medical University, Zunyi, 563000, China.
Xiaoming LiDepartment of Immunology, Zunyi Medical University, Zunyi, 563000, China.
Dan ZhangZunyi Medical University Library, Zunyi, 563000, China.
Shengxi ZhangDepartment of Immunology, Zunyi Medical University, Zunyi, 563000, China.
He ZhouDepartment of Immunology, Zunyi Medical University, Zunyi, 563000, China.
Ji CaiDepartment of Immunology, Zunyi Medical University, Zunyi, 563000, China.
Tao SongDepartment of Immunology, Zunyi Medical University, Zunyi, 563000, China.
Xianyao WangDepartment of Immunology, Zunyi Medical University, Zunyi, 563000, China.
Qinghong KongGuizhou Provincial College-based Key Lab for Tumor Prevention and Treatment with Distinctive Medicines, Zunyi Medical University, Zunyi, 563000, China.
Zhengzhen TangDepartment of Pediatrics, Third Affiliated Hospital of Zunyi Medical University, The First People's Hospital of Zunyi), Zunyi, 563000, China. Tangzz957150@163.com.
Jun TanDepartment of Histology and Embryology, Zunyi Medical University, Zunyi, 563000, China. juntan_zmu@126.com.
Jidong ZhangDepartment of Immunology, Zunyi Medical University, Zunyi, 563000, China. jdzhang0851@163.com.

Funding

National Nature Science Foundation of China 82460290, 31960156, 32270848The Collaborative Innovation Center of Chinese Ministry of Education 2020-39The Science and Technology Support Program of Guizhou Province QKH[2023]506The Science and Technology Support Program of Guizhou Province QKH-zk[2025]357, QKH[2020]4Y192
6 · The paper itself

Abstract

The spontaneous phenomena known as liquid-liquid phase separation (LLPS) is caused by weak interactions between substances. Under specific circumstances, macromolecules like proteins and nucleic acids can dynamically aggregate to form biomolecular condensates. This phenomenon offers a novel perspective on the intricate spatiotemporal coordination within living cells. Recent research has shown that LLPS is crucial for the initiation and progression of cancer, mainly by influencing multiple cellular activities such as metabolism, autophagy, stress responses, immune reactions, transcriptional regulation and intracellular signaling pathways, etc. Dysregulation of LLPS significantly affects the proliferation, metastasis, and therapeutic resistance of hepatocellular carcinoma (HCC) cells. Here, we introduce recent advances in understanding how LLPS regulates HCC-associated signaling pathways. Furthermore, we discuss the molecular mechanisms underlying the LLPS of oncogenic signaling molecules and its potential implication. Finally, we summarize several feasible approaches for treating HCC by targeting LLPS. These findings have the potential to establish a novel theoretical framework and therapeutic hypothesis for cancer treatment, thus providing more precise and individualized clinical strategies and significantly enhance patient prognosis and overall survival rates.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsAnimalsHumansPhase SeparationSignal TransductionBiomolecular condensatesHepatocellular carcinomaLiquid-liquid phase separationSignaling pathwayTargeted therapy

Identifiers

PMID40890761
PMCPMC12400693

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.